|
RBM17 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.897800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.869800E-01 |
| Normal-vs-Stage2 |
1.469980E-01 |
| Normal-vs-Stage3 |
3.430800E-01 |
| Normal-vs-Stage4 |
3.118100E-02 |
| Stage1-vs-Stage2 |
2.978300E-02 |
| Stage1-vs-Stage3 |
8.643600E-01 |
| Stage1-vs-Stage4 |
1.441370E-01 |
| Stage2-vs-Stage3 |
5.141600E-02 |
| Stage2-vs-Stage4 |
4.938600E-03 |
| Stage3-vs-Stage4 |
2.829800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.125590E-01 |
| Normal-vs-AfricanAmerican |
4.971600E-01 |
| Normal-vs-Asian |
7.574500E-02 |
| Caucasian-vs-AfricanAmerican |
8.128600E-01 |
| Caucasian-vs-Asian |
3.923800E-01 |
| AfricanAmerican-vs-Asian |
4.109600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.825190E-01 |
| Normal-vs-Female |
4.584200E-01 |
| Male-vs-Female |
3.777000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.825580E-01 |
| Normal-vs-Age(41-60Yrs) |
2.105200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.030200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.189600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.412200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.372360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.090400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.651590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.557600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.131600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.201400E-01 |
| Classical-VS-Follicular |
2.1094237467878E-15 |
| Classical-VS-Other |
4.425600E-01 |
| Classical-VS-Normal |
1.723820E-03 |
| Tall-VS-Follicular |
3.73019999999613E-07 |
| Tall-VS-Other |
3.374000E-01 |
| Tall-VS-Normal |
1.732360E-02 |
| Follicular-VS-Other |
8.459700E-02 |
| Follicular-VS-Normal |
1.56579999999185E-05 |
| Other-VS-Normal |
9.130000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.631640E-01 |
| Normal-vs-N1 |
8.264200E-02 |
| N0-vs-N1 |
1.089830E-02 |
|
|
